Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Society for Laboratory Automation and Screening Fully Established

By LabMedica International staff writers
Posted on 04 Aug 2010
On July 1, 2010, after almost two years strategizing, the Society for Biomolecular Sciences (SBS) and the Association for Laboratory Automation (ALA) united as one inclusive organization--the Society for Laboratory Automation and Screening (SLAS; IL, USA).

SBS and ALA will constitute individual sections of SLAS. More...
Each section will continue to pursue its current mission. The current SBS mission is to advance the science and technology of drug discovery and the use and development of biomolecular screening technology.

The current ALA mission is to further science and education related to laboratory automation, and in particular to encourage and advance the study and to improve the practice of laboratory automation.

SBS's and ALA's former identities and specialized educational programs will be preserved. Both will benefit from the expanded scope, international influence, and enhanced program and service offerings that the unified organization, SLAS, will provide.

The Journal for Biomolecular Screening (JBS) and Journal of the Association for Laboratory Automation (JALA) will continue their publishing schedules and immediate educational programs will take place as scheduled.

The CEO of SLAS, Greg Dummer, outlined the new society's aims. "Our objective right now is to be ready for business as a united new entity sometime later this year. With the traditional SBS and ALA conferences and exhibitions set for the first quarter of 2011, we have to maintain a high level of focus and determination; and we must look to appropriately blend some aspects of SLAS into each of these events."

During the transition period, which will take place throughout 2011, the new SLAS board of directors, with the leadership of the SBS and ALA sections will develop the long-range strategy.

The SALS is a not-for-profit corporation organized and operated exclusively for charitable, educational, and scientific purposes. Its aim is to be the preeminent global organization providing forums for education and information exchange pertaining to laboratory automation and screening.

Related Links:

Society for Biomolecular Sciences
Association for Laboratory Automation




New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.